Together with the PPARγ inhibition of lung cancer proliferation as previously reported [38, 39], this result suggests that PPARγ suppression of COX2 expression might be important in modulating oncogene-induced malignant transformation of HBECs into lung cancer. The gene discussed is PTGS2; the disease is lung carcinoma.